Neuphoria Therapeutics (NEUP) Receivables (2020 - 2025)
Historic Receivables for Neuphoria Therapeutics (NEUP) over the last 6 years, with Q4 2025 value amounting to -$609588.0.
- Neuphoria Therapeutics' Receivables fell 172202.12% to -$609588.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$609588.0, marking a year-over-year decrease of 172202.12%. This contributed to the annual value of $12185.0 for FY2025, which is N/A changed from last year.
- According to the latest figures from Q4 2025, Neuphoria Therapeutics' Receivables is -$609588.0, which was down 172202.12% from $3516.0 recorded in Q3 2025.
- Neuphoria Therapeutics' 5-year Receivables high stood at $4.9 million for Q2 2022, and its period low was -$609588.0 during Q4 2025.
- In the last 5 years, Neuphoria Therapeutics' Receivables had a median value of $37582.0 in 2024 and averaged $690340.6.
- Per our database at Business Quant, Neuphoria Therapeutics' Receivables tumbled by 8253.42% in 2023 and then tumbled by 172202.12% in 2025.
- Quarter analysis of 5 years shows Neuphoria Therapeutics' Receivables stood at $817326.8 in 2021, then soared by 494.53% to $4.9 million in 2022, then crashed by 82.53% to $848708.2 in 2023, then plummeted by 95.57% to $37582.0 in 2024, then crashed by 1722.02% to -$609588.0 in 2025.
- Its Receivables stands at -$609588.0 for Q4 2025, versus $3516.0 for Q3 2025 and $12185.0 for Q2 2025.